Summary
Islet A and B cells were purified from the rat pancreas and examined for their respective sensitivity to somatostatin. Both somatostatin-14 (S14) and -28 (S28) inhibited glucagon and insulin release through direct interactions with the corresponding cell types. A dose-dependent suppression of the secretory activities was paralleled by a reduction in cellular cyclic AMP formation with similar ED50 values for both actions. The somatostatin effects on pancreatic hormone release may thus be mediated via an inhibition of adenylate cyclase activity. In pancreatic A cells, S14 and S28 were equally potent inhibitors with ED50 values ranging from 2 × 10−12 to 2 × 10−11 mol/l. Pancreatic B cells exhibited a similar sensitivity to S28 as the A cells (ED50 of 2 to 5 × 10−11 mol/l), but not to S14 (ED50 of 2 × 10−9 mol/l). Extrapolation of these in vitro sensitivities of islet A and B cells to the in vivo situation suggests that both cell types can respond to circulating S28 levels and that A cells are sensitive to both locally and distally released S14. Islet B cells appear insensitive to the normal peripheral S14 levels but could respond to locally released somatostatin. The marked difference in the sensitivities of islet A and B cells to S14 suggests that these cell types are equipped with different somatostatin receptors. This notion was further supported by the cell-selective actions of the synthetic S14 analogues [D-Trp8, D-Cys14]S14 and desAsn5[D-Trp8, D-Ser13]Sl4.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77–79
Luft R, Efendic S, Hökfelt T, Johansson O, Arimura A (1974) Immunohistochemical evidence for the localization of somatostatinlike immunoreactivity in a cell population of the pancreatic islets. Med Biol 52: 428–430
Dubois MP (1975) Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci USA 72: 1340–1343
Polak JM, Grimelius L, Pearse AGE, Bloom SR, Arimura A (1975) Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet II: 1220–1222
Arimura A, Sato H, Dupont A, Nishi N, Schally AV (1975) Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science 189: 1007–1009
Hökfelt T, Efendic S, Johansson O, Luft R, Arimura A (1974) Immunohistochemical localization of somatostatin (growth hormone releasing-inhibiting factor) in the guinea-pig brain. Brain Res 80: 165–169
Hobart P, Crawford R, Shen LP, Pictet R, Rutter WJ (1980) Cloning and sequence analysis of cDNAs encoding two distinct somatostatin precursors found in the endocrine pancreas of anglerfish. Nature 288: 137–141
Goodman RH, Aron DC, Roos BA (1983) Rat pre-prosomatostatin: structure and processing by microsomal membranes. J Biol Chem 258: 5570–5573
Pradayrol L, Jörnvall H, Mutt V, Ribet A (1980) N-terminally extended somatostatin: the primary structure of somatostatin-28. Febs Lett 109: 55–58
Benoit R, Böhlen P, Brazeau P, Ling N, Guillemin R (1980) Isolation and characterization of rat pancreatic somatostatin. Endocrinology 107: 2127–2129
Patel YC, Wheatley T, Ning C (1981) Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat. Endocrinology 109: 1943–1949
Gluschankof P, Morel A, Gomez S, Nicolas P, Fahy C, Cohen P (1984) Enzymes processing somatostatin precursors: an Arg-Lys esteropeptidase from the rat brain cortex converting somatostatin-28 into somatostatin-14. Proc Natl Acad Sci USA 81: 6662–6666
Reichlin S (1983) Somatostatin. N Engl J Med 309: 1495–1501 (part I) and 1556–1563 (part II)
Alberti KGMM, Christensen SE; Iversen J, Seyer-Hansen K, Christensen NJ, Prange Hansen AA, Lundbaek K, Ørskov H (1973) Inhibition of insulin secretion by somatostatin. Lancet II: 1299–1301
Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J, Gale CC (1974) Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184: 482–484
Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R (1981) Selective effects of somatostatin-14, -25 and-28 on in vitro insulin and glucagon secretion. Nature 291: 76–77
Brown M, Rivier J, Vale W (1981) Somatostatin 28: selective action on the pancreatic β-cell and brain. Endocrinology 108: 2391–2393
Pipeleers DG, Pipeleers-Marichal MA (1981) A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 20: 654–663
Pipeleers DG, In't Veld PA, Van De Winkel M, Maes E, Schuit FC, Gepts W (1985) A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117: 806–816
Van de Winkel M, Maes E, Pipeleers D (1982) Islet cell analysis and purification by light scatter and autofluorescence. Biochem Biophys Res Commun 107: 525–532
Pipeleers D, Van De Winkel M (1986) Pancreatic B cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci USA 83: 5267–5271
Pipeleers DG, Schuit FC, Van Schravendijk CFH, Van De Winkel M (1985) Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117: 817–823
Pipeleers DG, Schuit FC, In't Veld PA, Maes E, Hooghe-Peters EL, Van De Winkel M, Gepts W (1985) Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117: 824–833
Schuit FC, Pipeleers DG (1986) Differences in adrenergic recognition by pancreatic A and B cells. Science 232: 875–877
Schuit FC, Pipeleers DG (1985) Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117: 834–840
van Schravendijk CFH, Foriers A, Hooghe-Peters EL, Rogiers V, De Meyts P, Sodoyez JC, Pipeleers DG (1985) Pancreatic hormone receptors on islet cells. Endocrinology 117: 841–848
Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. Wiley, New York, p 30
Govindarajulu Z (1988) Statistical techniques in bioassay. Karger, Basel, pp 28–34
Commisariat à l'Energie Atomique (1978) Statistique Appliquée à l'Exploitation des Mesures. Masson, Paris, p 371
Heisler S, Reisine TD, Hook VYH, Axelrod J (1982) Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells. Proc Natl Acad Sci USA 79: 6502–6506
Jakobs KH, Schulte G (1983) Occurrence of a hormone-sensitive inhibitory coupling component of the adenylate cyclase in S49 lymphoma eye-variants. Proc Natl Acad Sci USA 80: 3899–3902
Koch BD, Schonbrunn A (1984) The somatostatin receptor is directly coupled adenylate cyclase in GH4C1 pituitary cell membranes. Endocrinology 114: 1784–1790
Reisine T (1985) Multiple mechanisms of somatostatin inhibition of adrenocorticotropin release from mouse anterior pituitary tumor cells. Endocrinology 116: 2259–2266
Koch BD, Dorflinger LJ, Schonbrunn A (1985) Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. J Biol Chem 260: 13138–13145
Mackes K, Itoh M, Greene K, Gerich J (1981) Radioimmunoassay of human plasma somatostatin. Diabetes 30: 728–734
van Schravendijk CFH, Foriers A, Van den Brande JL, Pipeleers DG (1987) Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121: 1784–1788
Bonner-Weir S, Orci L (1982) New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31: 883–889
Kawai K, Ipp E, Orci L, Perrelet, Unger RH (1982) Circulating somatostatin acts on the islets of Langerhans by way of a somatostatin-poor compartment. Science 218: 477–478
Brown M, Rivier J, Vale W (1976) Somatostatin analogs with selected biological activities. Science 196: 1467–1469
Vale W, Rivier J, Ling N, Brown M (1978) Biologic and immunologic activities and applications of somatostatin analogs. Metabolism 27: 1391–1401
Taborsky GJ Jr, Smith PH, Porte D Jr (1979) Differential effects of somatostatin analogues on α- and β-cells of the pancreas. Am J Physiol 236: E123-E128
Amherdt M, Patel YC, Orci L (1987) Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest 80: 1455–1458
Author information
Authors and Affiliations
Additional information
Part of this study has been presented at the 21st Annual Meeting of the European Association for the Study of Diabetes, Rome, Italy, 1986
Rights and permissions
About this article
Cite this article
Schuit, F.C., Derde, M.P. & Pipeleers, D.G. Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 32, 207–212 (1989). https://doi.org/10.1007/BF00265096
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00265096